TAMMY GUFFEY: Open Payments
NPI 1649949645 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 16 payments from 14 companies in 2025. Trend: 2023 $492 · 2024 $632 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Amgen Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $26 |
| CSL Behring | 1 | $26 |
| Optinose US, Inc. | 1 | $24 |
| Octapharma USA, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: TEZSPIRE, DUPIXENT, Ohtuvayre, Andembry, Xhance, PANZYGA, NEMLUVIO, EBGLYSS.
Industry payments across KY — which companies pay providers there.
